Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Targeting amyloid-beta, a novel approach in glaucoma therapy

Aug. 13, 2007

Lux Biosciences' LX-211 granted fast track designation for the treatment of uveitis

Aug. 8, 2007

Regeneron and Bayer begin phase III study of VEGF Trap-Eye for wet AMD

Aug. 8, 2007

Orphan drug designation of LX-211 recommended by EMEA committee

Aug. 7, 2007

TargeGen begins phase II trial of TG-100801 eye drops for AMD

Aug. 6, 2007

Alcon's Travatanz approved in Japan for glaucoma and ocular hypertension

Aug. 2, 2007

OSI transfers all rights to E-10030 and PDGF program to Ophthotech

July 31, 2007

Bausch & Lomb Ireland withdraws Retisert marketing authorization application

July 27, 2007

Preclinical antiglaucomal efficacy of the novel prostanoid FP receptor agonist tafluprost presented

July 24, 2007

Acadia receives milestone payment for drug candidate for glaucoma

July 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...